Back to Search
JENNIFER ORBE, DO
DO
Pediatric Emergency Medicine (Pediatrics) Physician
NPI: 1629498555Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
336104898(IL)
Pediatric Emergency Medicine (Pediatrics) PhysicianPrimary
Pediatrics — Pediatric Emergency Medicine
Code: 2080P0204X
2017022736(MO)
Research & Publications (20)
The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
PMID 19473660·Atherosclerosis·2009
8-other
Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli.
PMID 17981764·Front Biosci·2008
6-review
Association between matrix metalloproteinase-10 concentration and smoking in individuals without cardiovascular disease.
PMID 19080965·Rev Esp Cardiol·2008
8-other
[Association of age, inflammatory markers and subclinical atherosclerosis in subjects free from cardiovascular disease].
PMID 18842208·Med Clin (Barc)·2008
8-other
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
PMID 18278189·Thromb Haemost·2008
4-observational
[Metalloproteases, vascular remodeling and atherothrombotic syndromes].
PMID 17915152·Rev Esp Cardiol·2007
6-review
Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis.
PMID 17059420·J Thromb Haemost·2007
8-other
Vulnerable plaque versus vulnerable patient: emerging blood biomarkers for risk stratification.
PMID 17897046·Endocr Metab Immune Disord Drug Targets·2007
6-review
Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.
PMID 17194891·Arterioscler Thromb Vasc Biol·2007
4-observational
Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.
PMID 17272745·Arterioscler Thromb Vasc Biol·2007
8-other
Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients.
PMID 17461937·J Thromb Haemost·2007
8-other
[Cyclooxygenase-2: a new therapeutic target in atherosclerosis?].
PMID 16792983·Med Clin (Barc)·2006
6-review
A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction.
PMID 16843451·Cardiovasc Res·2006
4-observational
The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin.
PMID 16879223·J Thromb Haemost·2006
8-other
Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.
PMID 16458279·Clin Chim Acta·2006
8-other
[4G/5G polymorphisms of PAI-1 in the metabolic syndrome].
PMID 16510100·Med Clin (Barc)·2006
4-observational
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
PMID 16580524·J Am Coll Cardiol·2006
8-other
[Fibrinogen. An old hemostatic protein with a new function: non-invasive marker of subclinical atherosclerosis].
PMID 15927107·Med Clin (Barc)·2005
6-review
Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?
PMID 16101563·Curr Drug Targets Cardiovasc Haematol Disord·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 1400 US HIGHWAY 61
FESTUS, MO 63028 - Phone
- (636) 933-1111
Quick Facts
- NPI
- 1629498555
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile